Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News

9/29/2023 Study by RNC Pharma and Medvestnik: More than 90% of Russian Doctors Support Simpler Accreditation

Almost half of the respondents, 49.5%, believe that this change is long overdue, since most doctors view accreditation as nothing more than a bureaucratic procedure. Another 22.8% say that the current approaches to personnel policy in healthcare should be changed completely.

9/28/2023 Pharmaceutical Drug Production in Russia (August 2023)

In January–August 2023, Russian manufacturers produced 455.8 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), up 0.9% from the same period last year, which is the first positive growth rate since January 2023. In physical terms, the production volume was 2.61 billion packages, down 5.3% from January–August 2022, or 51.4 billion minimum dosage units (MDUs), down 2.4%.

8/24/2023 Pharmaceutical Drug Production in Russia (July 2023)

From January to July 2023, Russian manufacturers produced 398.6 billion rubles’ worth of ready-made drugs (manufacturer’s prices, VAT included), down 0.3% from the same period in 2022. In physical terms, 2.26 billion packages were produced, down 6.9% from January–July 2022. If calculated in minimum dosage units (MDU), the production volume was 44.8 billion, down 2.3%.

8/21/2023 RNC Pharma: Pharmaceutical Logistics Operators Deal with Shortages of Storage Capacities and Experienced Personnel

Comprehensive ranking of logistics operators in the Russian pharmaceutical market in 2022.

8/2/2023 Study by RNC Pharma and Medvestnik: Less Than 7% of Russian Doctors Back Abortion Ban in Private Clinics and Limited Sale of Abortion Pills in Pharmacies

Almost 80% of Russian doctors oppose the initiatives to increase the birth rate proposed by the Ministry of Health and the State Duma of the Russian Federation, according to a survey conducted by the RNC Pharma analyst company and the Medvestnik platform for doctors. In particular, 47.3% of the respondents consider these measures “perfunctory”, since only an increased welfare of the population and more social benefits can guarantee a decreased abortion rate.

7/27/2023 Pharmaceutical Drug Production in Russia (June, January–June 2023)

In January–June 2023, Russian manufacturers produced 342.5 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 2.6% from the same period in 2022. In physical terms, the production volume was 1.97 billion packages, down 8.2%, or 39.0 billion minimum dosage units (MDU), down 3.8%.

6/29/2023 Pharmaceutical Drug Production in Russia (May 2023)

In January–May 2023, Russian manufacturers produced 282 billion rubles’ of pharmaceutical drugs (manufacturer’s prices, VAT included), down 5.8% from the same period in 2022. In physical terms, the production volume was 1.64 billion packages, down 9.7% from January–May 2022. If calculated in minimum dosage units (MDU), Russian manufacturers produced 32.2 billion MDUs, down 3.9% from January–May 2022.

6/19/2023 Top 20 Online Pharmaceutical Retailers in Russia in Q1 2023

In January–March 2023, the online sales or reservations of pharmacy products (pharmaceutical drugs and parapharmaceuticals) in Russia were 80.2 billion rubles (end-user prices, VAT included), up 2.3% from January–March 2022 (against 69.6% in Q1 2022, with its rush demand). This year, however, the online segment has entered a phase of stagnation due to the fact that further development might no longer be possible, when the experimental online sale of prescription drugs launched on March 1, 2023 is stalling.

6/2/2023 RNC Pharma: Top Russian Pharma Wholesaler Changed, Concentration Ratios Dropped

Russian Pharmaceutical Distributor Rankings in Q1 2023